Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

APTO Aptose Biosciences Inc

0,2851

0,012 (4,39%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:49:14

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Aptose Biosciences Charts.

Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Aptose Biosciences Charts.

News Aptose Biosciences Inc

Form 8-K - Current report
Mittwoch 20 November 2024 (1 Tag vor) • Edgar (US Regulatory)

Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
Mittwoch 20 November 2024 (1 Tag vor) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Donnerstag 14 November 2024 (7 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 8 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Aptose Reports Results for the Third Quarter 2024
Freitag 8 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Donnerstag 31 Oktober 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 4 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 6 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 5 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Aptose Announces Results from Special Meeting of Shareholders
Donnerstag 5 September 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 30 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib
Freitag 30 August 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Aptose Biosciences Inc News-Artikel

ICFZ24 - Dezembro 2024

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen